For: | Gil-Gómez A, Rojas Á, Liu CH, Gallego-Duran R, Muñoz-Hernandez R, Fassina G, Pontisso P, Ampuero J, Romero-Gómez M. Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- and long-term prediction of hepatocellular carcinoma among cirrhotic patients. World J Gastroenterol 2021; 27(48): 8343-8356 [PMID: 35068873 DOI: 10.3748/wjg.v27.i48.8343] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i48/8343.htm |
Number | Citing Articles |
1 |
Sophie Schlosser, Deniz Tümen, Barbara Volz, Katja Neumeyer, Niklas Egler, Claudia Kunst, Hauke Christian Tews, Stephan Schmid, Arne Kandulski, Martina Müller, Karsten Gülow. HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1016952
|
2 |
Lin Su, Jiawen Bu, Jiahui Yu, Mila Jin, Guanliang Meng, Xudong Zhu. Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application. Clinical and Translational Medicine 2024; 14(11) doi: 10.1002/ctm2.70066
|
3 |
Lewis R. Roberts. Surveillance for Hepatocellular Carcinoma. Clinics in Liver Disease 2025; 29(1): 17 doi: 10.1016/j.cld.2024.09.001
|
4 |
Yong Liang, Zhen Liu, Dongliang Zuo, Shi Chen, Jianbin Chen, Xiaowen Yan, Pingguo Liu, Qiuquan Wang. Single cell glycan-linkages profiling for hepatocellular carcinoma early diagnosis using lanthanide encoded bacteriophage MS2 based ICP-MS. Talanta 2024; 274: 126056 doi: 10.1016/j.talanta.2024.126056
|
5 |
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Elisabetta Bugianesi. An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance. Metabolism 2025; 162: 156080 doi: 10.1016/j.metabol.2024.156080
|